Levodopa with carbidopa and entacapone - Parkinson's disease
You are here : Home > Formulary Search > Levodopa with carbidopa and entacapone - Parkinson's disease
Status 1
- Tablets
Status 2
- Intestinal gel
This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an applicationto the APC.
Documentation
- No records returned.
PAD Profile
Other Indications
Below are listed other indications that Levodopa with carbidopa and entacapone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease.
- Amantadine hydrochloride
- Apomorphine hydrochloride
- Bromocriptine
- Cabergoline
- Clonazepam
- Co-beneldopa
- Co-careldopa
- Entacapone
- Foslevodopa with foscarbidopa
- Melatonin
- Opicapone
- Orphenadrine hydrochloride
- Pergolide mesilate
- Pramipexole
- Procyclidine hydrochloride
- Rasagiline mesilate
- Ropinirole hydrochloride
- Rotigotine
- Safinamide
- Selegiline hydrochloride
- Tolcapone
- Trihexyphenidyl hydrochloride
Committee Recommendations (1)
INTESTINAL GEL:
This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.
This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.
Before prescribing this drug/device it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.
The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net if they wish to make a submission.